Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOweL Diseases
Observational · No treatment assigned · 1 site · IRCCS Azienda Ospedaliero-Universitaria di Bologna
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Cytomegalovirus (CMV) and Inflammatory Bowel Disease (IBD). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Patients aged ≥18 years with Inflammatory Bowel Disease (IBD) with worsening of IBD-related symptoms requiring hospital admission
- Signing of informed consent
- Performed endoscopic biopsies to confirm/exclude CMV organ disease
Only the trial team can confirm whether you qualify.
What's involved
- About 200 participants are expected to take part.
- Start date: 2024-04-02.
- Main results expected around 2026-12-31 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Italy.
Main thing being measured
- Diagnostic Performance of CMV-DNA Quantification in Blood and Fecal Samples Compared to Immunohistochemistry on Biopsy for CMV Infection Diagnosis (Each samples taken from the patients will be tested through study completion (average of 2 year))
In the researchers’ words
Observational, single-center, non-pharmacological, prospective study of adult patients affected by Inflammatory Bowel Disease (IBD) with an ongoing disease exacerbation requiring hospitalization
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Cytomegalovirus (CMV); Inflammatory Bowel Disease (IBD) |
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Enrollment | 200 (estimated) |
| Start date | 2024-04-02 |
| Primary completion (est.) | 2026-12-31 |
| First posted | 2025-01-27 |
| Last updated | 2026-06-15 |
| Official title | Comparison of Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With Intestinal BOweL Diseases |
| ClinicalTrials.gov ID | NCT06793124 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients aged ≥18 years with Inflammatory Bowel Disease (IBD) with worsening of IBD-related symptoms requiring hospital admission * Signing of informed consent * Performed endoscopic biopsies to confirm/exclude CMV organ disease Exclusion Criteria: /
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Bologna | Italy | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.